SAGE meeting of November 2012
Salle A, CCV, Geneva, 6-8 November 2012
Presentations
Session: Report from Director, IVB
Session: Report from GAVI
Session: Reports from other Advisory Committees on Immunization
-
Report of the Global Advisory Committee on Vaccine Safety (GACVS)
pdf, 631kb
M. Wharton, Chair of GACVS -
Report of the Immunization Practices Advisory Committee (IPAC)
pdf, 771kb
S. Deeks, Chair of IPAC -
Report of the Expert Committee on Biological Standardization (ECBS)
pdf, 562kb
E. Griffiths, Chair of ECBS -
Report of the Immunization and Vaccine Related Implementation Research Advisory Committee (IVIR-AC)
pdf, 142kb
A. Hinman, Chair of IVIR-AC
Session: Polio eradication initiative
-
Context: Major developments since SAGE April 2012 meeting
pdf, 1.02Mb
B. Aylward, WHO -
Polio Endgame Strategy, Legacy & Budget, 2014-2018
pdf, 758kb
A. Freeman, GPEI -
Role of IPV in OPV cessation – report of the SAGE Polio Working group
pdf, 297kb
E. Miller, Chair of SAGE Polio Working Group -
Accelerating polio emergency eradication efforts - is there a role for expanding the target age groups for bOPV campaigns and/or including IPV in campaigns
pdf, 2.11Mb
H. Jafari, WHO
Session: Decade of Vaccines (DoV) and Global Vaccine Action Plan (GVAP)
-
GVAP key steps to implementation
pdf, 839kb
J.-M. Okwo-Bele, WHO -
Decade of Vaccine M&E/Accountability Framework
pdf, 1.84Mb
T. Cherian, WHO -
GVAP Costing, Financing and impact update and tracking commitments
pdf, 246kb
G. Gandhi, UNICEF -
Independent review of progress and reporting to governing bodies
pdf, 539kb
P. Duclos, WHO
Session: Hib immunization schedule
-
Overview of Hib burden and progress with vaccine introduction (and questions to SAGE)
pdf, 450kb
P. Fine, London School of Hygiene and Tropical Medicine (LSHTM) -
What evidence is available on the current Hib vaccine schedule versus alternative schedules
pdf, 272kb
R. Hajjeh, CDC -
Impact and incremental benefits of various Hib vaccines schedules given the disease epidemiology in young children and the actual age at vaccination
pdf, 1.21Mb
C. Sanderson, LSHTM -
Expert group conclusions: What are the optimal schedules for Hib vaccines for children living in different epidemiological settings?
pdf, 1.99Mb
J. Abramson, SAGE member
Session: Measles and rubella status report
-
Presentation on progress and challenges to achieving global and regional goals
pdf, 3.19Mb
P. Figueroa, SAGE member and chair of SAGE working group on measles and rubella -
Presentation on opportunities and plans to overcome the challenges
pdf, 1.38Mb
P. Strebel, WHO -
Presentation on the draft framework for verifying elimination of measles and rubella
pdf, 210kb
N. Crowcroft, SAGE working group on measles and rubella -
Aerosol measles vaccination
pdf, 4.78Mb
M. Greco, Chair of the aerosol product development group and A.-M. Henao, WHO
Session: Vaccination in humanitarian emergencies
-
Introduction and overview of the process; and the three components of the work
pdf, 71kb
H. Rees, Chair of SAGE working group on vaccination in humanitarian emergencies -
The decision-making framework
pdf, 219kb
R. Waldman, SAGE working group on vaccination in humanitarian emergencies
Session: New vaccine introduction in middle-income countries
What is the new context regarding middle-income countries and new vaccine introduction?
-
Report from Macedonia
pdf, 203kb
S. Manevska, Ministry of Health, The former Yugoslav Republic of Macedonia -
EURO report
pdf, 319kb
L. Mosina, WHO EURO
-
What has been done so far to implement SAGE 2010 recommendations?
pdf, 876kb
S. Schmitt, WHO consultant -
What is to be done to respond to country needs and comply with WHA and SAGE recommendations: What WHO and partners are exploring and planning to do?
pdf, 765kb
M. Kaddar, WHO -
Developing a strategy to support new vaccines introduction to Middle Income Countries
pdf, 327kb
M. Shirey, UNICEF